2,053
Views
2
CrossRef citations to date
0
Altmetric
Health Financing

Cost, healthcare utilization, and outcomes of antibody-mediated rejection in kidney transplant recipients in the US

, , , , &
Pages 1011-1017 | Received 10 May 2021, Accepted 02 Aug 2021, Published online: 18 Aug 2021

Figures & data

Table 1. Codes and time frames examined to determine an algorithm to detect AMR in CMS claims data.

Table 2. Matching variables by group after matching.

Table 3. Healthcare utilization per patient in the 60 d prior to AMR event.

Table 4. Healthcare utilization per patient-year after AMR event (censored at death or 2 years years).

Figure 1. Cost per patient 60 d before AMR diagnosis for AMR-defined patients only.

Figure 1. Cost per patient 60 d before AMR diagnosis for AMR-defined patients only.

Figure 2. Cost per patient-year 2 years after AMR diagnosis for AMR-defined patients only.

Figure 2. Cost per patient-year 2 years after AMR diagnosis for AMR-defined patients only.

Table 5. Healthcare costs per patient up to 60 d before AMR event.

Table 6. Healthcare costs per patient-year after AMR event (censored at death or 2 years years).

Data availability statement

The data that support the findings of this study are available from the DeKAF investigators upon reasonable request, and CMS claims data are publicly available.